p16(CDKN2) gene polymorphism:: association with histologic subtypes of epithelial ovarian cancer in China

被引:18
|
作者
Yan, L. [1 ,2 ]
Na, W. [2 ]
Shan, K. [3 ]
Xiao-Wei, M. [3 ]
Wei, G. [2 ]
Shu-Cheng, C. [3 ]
机构
[1] Hebei Med Univ, Hosp 4, Hebei Canc Inst, Shijiazhuang 050011, Peoples R China
[2] Hebei Med Univ, Hosp 4, Dept Mol Biol, Shijiazhuang 050011, Peoples R China
[3] Hebei Med Univ, Hosp 4, Dept Obstet & Gynaecol, Shijiazhuang 050011, Peoples R China
基金
美国国家科学基金会;
关键词
epithelial ovarian cancer; haplotype; p16; single nucleotide polymorphism; susceptibility;
D O I
10.1111/j.1525-1438.2007.00953.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p16 is an important tumor suppressor gene, which is inactivated in many kinds of tumors. The common variants of p16 may be associated with the risk of certain tumors development. We analyzed the frequency of two adjacent polymorphisms in p16 exon 3 (540C -> G and 580C -> T) and their haplotype in blood samples from epithelial ovarian cancer (EOC) patients and healthy controls using polymerase chain reaction-restriction fragment length polymorphism. The results showed that the genotype frequency of p16 580C -> T polymorphism was significantly different among histologic subtypes of EOC (P = 0.02). T allele carriers significantly reduced the risk of serous EOC; the adjusted odds ratio was 0.40 (95% CI = 0.19-0.84). There are neither association between p16 540C -> G polymorphism and EOC development, progression, nor association between the haplotypes of two single nucleotide polymorphisms and the tumor development. Our results suggested that the p16 580C -> T polymorphism might affect the individual susceptibility to specific subtypes of EOC. Different types of ovarian cancer might adopt distinct carcinogenetic pathways. However, this result may be further validated in a larger sample of patients.
引用
收藏
页码:30 / 35
页数:6
相关论文
共 50 条
  • [21] Expression of p16 gene (CDKN2) increased cell adhesion of breast cancers.
    Yang, L
    Jin, G
    Shi, Y
    Bai, J
    Nobori, T
    Sung, P
    Yu, BF
    [J]. CANCER GENE THERAPY, 1996, 3 (06) : P112 - P112
  • [22] 肿瘤抑制基因CDKN2/p16与肺癌
    苏长青
    单祥年
    [J]. 癌症, 1999, (S1) : 131 - 133
  • [23] CDKN2/p16 predicts survival in oligodendrogliomas:: comparison with astrocytomas
    Miettinen, H
    Kononen, J
    Sallinen, P
    Alho, H
    Helen, P
    Helin, H
    Kalimo, H
    Paljärvi, L
    Isola, J
    Haapasalo, H
    [J]. JOURNAL OF NEURO-ONCOLOGY, 1999, 41 (03) : 205 - 211
  • [24] MUTATIONS OF THE CDKN2/P16(INK4) GENE IN AUSTRALIAN MELANOMA KINDREDS
    WALKER, GJ
    HUSSUSSIAN, CJ
    FLORE, JF
    GLENDENING, JM
    HALUSKA, FG
    DRACOPOLI, NC
    HAYWARD, NK
    FOUNTAIN, JW
    [J]. HUMAN MOLECULAR GENETICS, 1995, 4 (10) : 1845 - 1852
  • [25] Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens
    Jacqueline E. Calvano
    Elisa B. Rush
    Lee K. Tan
    Paul Peter Rosen
    Patrick I. Borgen
    Kimberly J. Van Zee
    [J]. Annals of Surgical Oncology, 1997, 4 : 416 - 420
  • [26] Focal distribution of p16/CDKN2 gene mutations within individual prostate carcinomas
    Konishi, N
    Hiasa, Y
    Tao, M
    Matsuda, H
    Nakamura, M
    Yane, K
    Kitahori, Y
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1996, 8 (03) : 549 - 554
  • [27] REPLACEMENT OF THE P16/CDKN2 GENE SUPPRESSES HUMAN GLIOMA CELL-GROWTH
    ARAP, W
    NISHIKAWA, R
    FURNARI, FB
    CAVENEE, WK
    HUANG, HJS
    [J]. CANCER RESEARCH, 1995, 55 (06) : 1351 - 1354
  • [28] Absence of p16 gene (CDKN2) deletions in microdissected primary breast carcinoma specimens
    Calvano, JE
    Rush, EB
    Tan, LK
    Rosen, PP
    Borgen, PI
    VanZee, KJ
    [J]. ANNALS OF SURGICAL ONCOLOGY, 1997, 4 (05) : 416 - 420
  • [29] CDKN2/p16基因存在状态与肺癌
    叶玉坤
    苏长青
    汪栋
    张志敏
    张卫兵
    单祥年
    [J]. 中华胸心血管外科杂志, 2000, (05) : 25 - 27
  • [30] Sporadic CDKN2 (MTS1/p16(ink4)) gene alterations in human ovarian tumours
    Schuyer, M
    vanStaveren, IL
    Klijn, JGM
    vanderBurg, MEL
    Stoter, G
    HenzenLogmans, SC
    Foekens, JA
    Berns, EMJJ
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (07) : 1069 - 1073